Article
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women.
Menopause (New York, N.Y.) - 1 Mar 2011
Nachtigall Margaret J, Jessel Rebecca H, Flaumenhaft Robert, Nachtigall Richard, Yoles Israel, Naftolin Frederick, Nachtigall Lila E
Abstract excerpt
OBJECTIVE: The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on platelet function in normal and thrombophilic women being treated for severe menopausal symptoms. METHODS: The Platelet Function Analyzer-100 (PFA-100) was used to asses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.